This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MinuteClinic Partners With DASH For Health To Create Personalized Weight Loss Program

WOONSOCKET, R.I., July 15, 2013 /PRNewswire/ -- MinuteClinic, a division of CVS Caremark and the largest provider of walk-in medical clinics in the United States, has created the Weight Loss Program at MinuteClinic, a convenient, personalized program to help patients lose weight and live a healthier lifestyle incorporating the proven DASH diet health plan. The DASH diet has been ranked the No. 1 Overall Diet by U.S. News & World Report for the past three years.

The Weight Loss Program at MinuteClinic combines weekly visits with a MinuteClinic practitioner plus nutrition and weight loss advice delivered via the online DASH for Health® program.  The program is tailored to each individual and includes a medical evaluation with lab tests (such as blood sugar and cholesterol screening). The DASH diet (DASH stands for Dietary Approaches to Stop Hypertension) has been clinically proven to promote weight loss, while lowering blood pressure and cholesterol.

"DASH is one of the most highly recommended, evidence-based diets in clinical practice today," said Nancy Gagliano, M.D., MinuteClinic chief medical officer. "Our Weight Loss Program is designed to help patients lose weight by making smart choices, and focuses on healthy eating with DASH-approved recipes. In addition to providing healthy dietary recommendations, MinuteClinic practitioners tailor a weight loss plan for each patient that incorporates counseling, education and advice to help patients achieve their goals."

According to the Centers for Disease Control (CDC), more than one-third of U.S. adults are obese. Obesity contributes to several health conditions, including heart disease, stroke and Type 2 diabetes. More than 1 in 3 Americans currently suffer from hypertension, according to the CDC. Also, diabetes is on the rise and now affects 25.8 million Americans according to data from the American Diabetes Association.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TSLA $238.02 -3.90%
YHOO $36.36 -0.63%
AAPL $93.15 -1.80%
FB $116.39 -0.29%
GOOG $691.93 0.13%


Chart of I:DJI
DOW 17,685.20 -145.56 -0.82%
S&P 500 2,055.98 -19.83 -0.96%
NASDAQ 4,759.3580 -45.9330 -0.96%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs